{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:05:22Z","timestamp":1790301922003,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.peptides.2019.170139","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T11:36:55Z","timestamp":1566992215000},"page":"170139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6212-9518","authenticated-orcid":false,"given":"Duuamene","family":"Nyimanu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhoda E.","family":"Kuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bednarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Ambery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Jermutus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet J.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2096-3117","authenticated-orcid":false,"given":"Anthony P.","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2019.170139_bib0005","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0378-1119(93)90495-O","article-title":"A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11","volume":"136","author":"O\u2019Dowd","year":"1993","journal-title":"Gene"},{"key":"10.1016\/j.peptides.2019.170139_bib0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2019.170139_bib0015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/pr.110.002949","article-title":"International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function","volume":"62","author":"Pitkin","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.peptides.2019.170139_bib0020","doi-asserted-by":"crossref","first-page":"10464","DOI":"10.1073\/pnas.0403518101","article-title":"Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release","volume":"101","author":"De Mota","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2019.170139_bib0025","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/HYPERTENSIONAHA.109.134619","article-title":"[Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease","volume":"54","author":"Maguire","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2019.170139_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2013.07.006","article-title":"Pyroglutamyl apelin-13 identified as the major apelin isoform in human plasma","volume":"442","author":"Zhen","year":"2013","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.peptides.2019.170139_bib0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.regpep.2003.11.002","article-title":"Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells","volume":"118","author":"Kleinz","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.peptides.2019.170139_bib0040","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pharmthera.2005.04.001","article-title":"Emerging roles of apelin in biology and medicine","volume":"107","author":"Kleinz","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.peptides.2019.170139_bib0045","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/JOE-13-0227","article-title":"The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis","volume":"219","author":"O\u2019Carroll","year":"2013","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.peptides.2019.170139_bib0050","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.tips.2015.06.002","article-title":"Apelin, Elabela\/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system","volume":"36","author":"Yang","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.peptides.2019.170139_bib0055","doi-asserted-by":"crossref","DOI":"10.1124\/pr.119.017533","article-title":"International Union of Basic and Clinical Pharmacology XXX. Structure and pharmacology of the apelin receptor with a recommendation that Elabela\/Toddler is a second endogenous peptide ligand","author":"Read","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.peptides.2019.170139_bib0060","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1471-4159.2004.02591.x","article-title":"Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure","volume":"90","author":"El Messari","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.peptides.2019.170139_bib0065","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jacc.2008.06.013","article-title":"Vascular effects of apelin in vivo in man","volume":"52","author":"Japp","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.peptides.2019.170139_bib0070","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/01.CIR.0000091235.94914.75","article-title":"Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction","volume":"108","author":"Chen","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2019.170139_bib0075","doi-asserted-by":"crossref","first-page":"II187","DOI":"10.1161\/01.CIR.0000138382.57325.5c","article-title":"Apelin has in vivo inotropic effects on normal and failing hearts","volume":"110","author":"Berry","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2019.170139_bib0080","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1172\/JCI43382","article-title":"Disruption of PPAR\u03b3\/\u03b2-catenin\u2013mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival","volume":"121","author":"Tero-Pekka Alastalo","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2019.170139_bib0085","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cmet.2008.10.003","article-title":"Apelin stimulates glucose utilization in normal and obese insulin-resistant mice","volume":"8","author":"Dray","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.peptides.2019.170139_bib0090","doi-asserted-by":"crossref","first-page":"E59","DOI":"10.1152\/ajpendo.00385.2009","article-title":"Apelin is necessary for the maintenance of insulin sensitivity","volume":"298","author":"Yue","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2019.170139_bib0095","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1210\/en.2006-1270","article-title":"Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice","volume":"148","author":"Higuchi","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2019.170139_bib0100","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1074\/jbc.M116.748103","article-title":"Apelin-36 modulates blood glucose and body weight independently of canonical APJ receptor signaling","volume":"292","author":"Galon-Tilleman","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2019.170139_bib0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nchem.1230","article-title":"Relieving PEGylation","volume":"4","author":"Parrott","year":"2012","journal-title":"Nat. Chem."},{"key":"10.1016\/j.peptides.2019.170139_bib0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcp.2016.07.018","article-title":"Cardiac action of the first G protein biased small molecule apelin agonist","volume":"116","author":"Read","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.peptides.2019.170139_bib0115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0160-5402(85)90034-8","article-title":"Analysis of radioligand binding experiments: a collection of computer programs for the IBM PC","volume":"14","author":"McPherson","year":"1985","journal-title":"J. Pharmacol. Methods"},{"key":"10.1016\/j.peptides.2019.170139_bib0120","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.116.023218","article-title":"Elabela\/Toddler is an endogenous agonist of the apelin APJ receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension","volume":"135","author":"Yang","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2019.170139_bib0125","doi-asserted-by":"crossref","DOI":"10.1111\/bph.14603","article-title":"A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertension","author":"Yang","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.peptides.2019.170139_bib0130","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1124\/mol.113.088880","article-title":"Quantification of ligand bias for clinically relevant \u03b22-adrenergic receptor ligands: implications for drug taxonomy","volume":"85","author":"van der Westhuizen","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.peptides.2019.170139_bib0135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1021\/cn200111m","article-title":"A simple method for quantifying functional selectivity and agonist bias","volume":"3","author":"Kenakin","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.peptides.2019.170139_bib0140","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1046\/j.1471-4159.2003.01587.x","article-title":"Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin","volume":"84","author":"Medhurst","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.peptides.2019.170139_bib0145","doi-asserted-by":"crossref","first-page":"10163","DOI":"10.1021\/bi030049s","article-title":"Structural and Functional Study of the Apelin-13 Peptide, an Endogenous Ligand of the HIV-1 Coreceptor, APJ","volume":"42","author":"Fan","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.peptides.2019.170139_bib0150","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/HYPERTENSIONAHA.114.05099","article-title":"Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist","volume":"65","author":"Brame","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2019.170139_bib0155","doi-asserted-by":"crossref","first-page":"32627","DOI":"10.1074\/jbc.M110.127167","article-title":"By interacting with the C-terminal phe of apelin, Phe255 and Trp259 in Helix vi of the apelin receptor are critical for internalization","volume":"285","author":"Iturrioz","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2019.170139_bib0160","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/HYPERTENSIONAHA.115.06892","article-title":"Angiotensin-converting enzyme 2 metabolizes and partially inactivates Pyr-Apelin-13 and Apelin-17: physiological effects in the cardiovascular system","volume":"68","author":"Wang","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2019.170139_bib0165","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fnins.2017.00092","article-title":"[Pyr1]Apelin-13(1\u201312) is a biologically active ACE2 metabolite of the endogenous cardiovascular peptide [Pyr1]Apelin-13","volume":"11","author":"Yang","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.peptides.2019.170139_bib0170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/en.2010-0576","article-title":"Apelin decreases lipolysis via gq, gi, and AMPK-Dependent mechanisms","volume":"152","author":"Yue","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2019.170139_bib0175","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/j.gastro.2013.01.004","article-title":"The intestinal glucose\u2013Apelin cycle controls carbohydrate absorption in mice","volume":"144","author":"Dray","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.peptides.2019.170139_bib0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1677\/JME-10-0105","article-title":"Apelin stimulates glucose uptake but not lipolysis in human adipose tissue ex vivo","volume":"46","author":"Attane","year":"2011","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.peptides.2019.170139_bib0185","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bcp.2017.10.002","article-title":"Acylated apelin-13 amide analogues exhibit enzyme resistance and prolonged insulin releasing, glucose lowering and anorexic properties","volume":"146","author":"O\u2019Harte","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.peptides.2019.170139_bib0190","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.peptides.2017.12.004","article-title":"Apelin-13 analogues show potent in vitro and in vivo insulinotropic and glucose lowering actions","volume":"100","author":"O\u2019Harte","year":"2018","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2019.170139_bib0195","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s12020-018-1536-1","article-title":"Chronic apelin treatment improves hepatic lipid metabolism in obese and insulin-resistant mice by an indirect mechanism","volume":"60","author":"Bertrand","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.peptides.2019.170139_bib0200","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrendo.2016.105","article-title":"Diabetes mellitus statistics on prevalence and mortality: facts and fallacies","volume":"12","author":"Zimmet","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.peptides.2019.170139_bib0205","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.bcp.2007.12.015","article-title":"The apelin-APJ system in heart failure. Pathophysiologic relevance and therapeutic potential","volume":"75","author":"Japp","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.peptides.2019.170139_bib0210","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00395-007-0671-2","article-title":"Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemiareperfusion injury","volume":"102","author":"Simpkin","year":"2007","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.peptides.2019.170139_bib0215","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/HJH.0b013e328344da76","article-title":"Reduced circulating apelin in essential hypertension and its association with cardiac dysfunction","volume":"29","author":"Przewlocka-Kosmala","year":"2011","journal-title":"J. Hypertens."},{"key":"10.1016\/j.peptides.2019.170139_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-011-9507-9","article-title":"Apelin, diabetes, and obesity","volume":"40","author":"Castan-Laurell","year":"2011","journal-title":"Endocrine"},{"key":"10.1016\/j.peptides.2019.170139_bib0225","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fphys.2015.00115","article-title":"Apelin and energy metabolism","volume":"6","author":"Bertrand","year":"2015","journal-title":"Front. Physiol."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978119301172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978119301172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:24:55Z","timestamp":1759310695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978119301172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":45,"alternative-id":["S0196978119301172"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2019.170139","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2019.170139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"170139"}}